Peter Stenvinkel
Peter Stenvinkel is an expert in Nephrology at Karolinska Institute (Sweden). As of October 2026, ScienceLeadR ranks Peter Stenvinkel in the top 1% of experts worldwide for Renal Insufficiency, Calcium Metabolism Disorders and Malnutrition. Peter Stenvinkel has authored 889 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 2,959 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Nutrition - Transplantation - Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1982 - 2026
Number : 889
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Global njurhälsa – hur kan vi möta den tysta pandemin? PMID 42678231 | Lakartidningen | 2026 | 0 |
| AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition. PMID 42650220 — kidney diseases, stress, physiological, kidney, rage | Antioxidants (Basel) | 2026 | 0 |
| Indoxyl Sulfate-Mediated Blood-Brain Barrier Damage in Chronic Kidney Disease. PMID 42646762 — blood-brain barrier, kidney diseases, cells, genes, indican, blood, stress, physiological, brain, kidney, oxidative stress, claudin-5, endothelial cells, claudins | Toxins (Basel) | 2026 | 0 |
| ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health. PMID 42521017 — diabetes mellitus, kidney diseases, cardiovascular diseases, kidney, obesity, therapeutics | Kidney Int | 2026 | 1 |
| Correction to: Genetic Variation and Ultrafiltration with Peritoneal Dialysis: A Genome-Wide Association Study. PMID 42485100 — kidney diseases, genetic variation, ultrafiltration, peritoneal dialysis, genome-wide association study, genome, nephrology | J Am Soc Nephrol | 2026 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The Effect of the Nutraceutical ( ) Epicatechin on Myosteatosis in Patients With Advanced CKD NCT06631820 — kidney diseases, pilot projects, tea, pilots, mitochondrial diseases, muscles, powders, kidney, food, renal insufficiency, breakfast, renal insufficiency, chronic | N/A | Recruiting | 2025 |
| Combined Dose Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) NCT05485961 — diabetes mellitus, kidney diseases, safety, coronary artery disease, myocardial infarction, excipients, cardiovascular diseases, kidney, arteries, kidney failure, chronic, atherosclerosis, peripheral arterial disease | Phase 2/Phase 3 | Recruiting | 2024 |
LeadR Networks
Main global connection map